Nanobusiness News

RSS
Unique Insight into Growing Global Market for Gold Nanoparticles

Unique Insight into Growing Global Market for Gold Nanoparticles

New Report on Global and China Nano Composite Zirconia Industry

New Report on Global and China Nano Composite Zirconia Industry

Air Products to Join SUNY Poly CNSE / SEMATECH Advanced Planarization Center at Albany Nanotech Complex

Air Products to Join SUNY Poly CNSE / SEMATECH Advanced Planarization Center at Albany Nanotech Complex

Trends in Nanotechnology International Conference 2015 Announces Names of Keynote Speakers

Trends in Nanotechnology International Conference 2015 Announces Names of Keynote Speakers

Cambridge Nanosystems Announces Opening of New Ultra-High-Quality Graphene Production Facility

Cambridge Nanosystems Announces Opening of New Ultra-High-Quality Graphene Production Facility

International Conference on Frontiers of Characterization and Metrology for Nanoelectronics 2015 Concludes Successfully

International Conference on Frontiers of Characterization and Metrology for Nanoelectronics 2015 Concludes Successfully

Synopsys Announces New Extensions to its Open-Source Interconnect Technology Format

Synopsys Announces New Extensions to its Open-Source Interconnect Technology Format

Blend Therapeutics Announces Presentation of Preclinical Data on Lead Pentarin Program, BTP-277

Blend Therapeutics Announces Presentation of Preclinical Data on Lead Pentarin Program, BTP-277

Cnano Completes $15 Million Series C Funding to Expand Carbon Nanotubes Manufacturing Operation

Cnano Completes $15 Million Series C Funding to Expand Carbon Nanotubes Manufacturing Operation

Oasmia's Paclical Nanoparticle Cancer Drug with Paclitaxel Receives Russian Health Ministry Market Authorization

Oasmia's Paclical Nanoparticle Cancer Drug with Paclitaxel Receives Russian Health Ministry Market Authorization

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.